A Randomized, Double-Blind, Controlled Trial of Percutaneous Tibial Nerve Stimulation With Pelvic Floor Exercises in the Treatment of Childhood Constipation

• Published in: The American journal of gastroenterology Vol. 118; no. 3; pp. 553 - 560
• Main Authors: Yu, Zheng-tong, Song, Jun-Min, Qiao, Lei, Wang, Yang, Chen, Ying, Wang, En-Hui, Zhang, Shu-Cheng
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer 01.03.2023; Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
• Subjects: Aged; Child; Childhood; Constipation; Constipation - therapy; Defecation; Drug-Related Side Effects and Adverse Reactions; Electrodes; Electromyography; Exercise Therapy; FDA approval; Fecal incontinence; Female; Humans; Methods; Patients; Pelvic Floor; Pelvis; Polyethylene glycol; Remission (Medicine); Tibial Nerve - physiology; Transcutaneous Electric Nerve Stimulation; Treatment Outcome; China
• ISSN: 0002-9270; 1572-0241; 1572-0241
• DOI: 10.14309/ajg.0000000000002188

The management of childhood constipation is challenging. Pelvic floor dysfunction (PFD) is one of the most common causes of childhood constipation. Percutaneous tibial nerve stimulation (PTNS) with pelvic floor exercises (PFE) has achieved a satisfactory outcome in the elderly individuals and women with PFD. The efficacy of PTNS with PFE in childhood constipation has not been established. A randomized, double-blind, controlled trial with 84 children who met the inclusion criteria was conducted. All participants were randomly assigned to PTNS with PFE or sham PTNS with PFE groups and received their individual intervention for 4 weeks with a 12-week follow-up evaluation. The spontaneous bowel movements (SBM) ≥3 per week were the main outcomes, and the risk ratio (RR) with 95% confidence interval (CI) were calculated. High-resolution anorectal manometry and surface electromyography were used for the assessment of pelvic floor function, and the adverse effects were assessed based on symptoms. At the end of the follow-up period, 26 patients (61.9%) in the PTNS with PFE group and 15 patients (35.7%) in the sham group had ≥3 SBM per week compared with baseline (net difference 26.2%, 95% CI 5.6%-46.8%; RR 2.750, 95% CI 1.384-5.466; P < 0.05). PFD remission occurred in 49 children, 33 (78.6%) in the PTNS with PFE group and 16 (38.1%) in the sham group (RR 2.063, 95% CI 1.360-3.128, P < 0.05). No adverse effects occurred. PTNS with PFE is a safe and effective method in the treatment of childhood constipation, particularly in children with PFD or dyssynergic defecation.